BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38926820)

  • 41. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
    Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
    J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do the 2013 United States Preventive Services Task Force guidelines for lung cancer screening fail high-risk African American smokers? An institutional retrospective observational cohort study.
    Thurlapati A; Velez-Martinez CS; Hirani S; Abad J; Shi R; Beedupalli K; Mansour RP
    Eur J Cancer Prev; 2021 Sep; 30(5):375-381. PubMed ID: 34010237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving identification of candidates for lung cancer screening in a high risk population.
    Waddle MR; Ko SJ; May J; Kaleem T; Miller DH; Stross WC; Malouff TD; Wert K; Cuthbert K; Landy R; Strong G; Vallow LA; Johnson MM
    Lung Cancer; 2020 Oct; 148():79-85. PubMed ID: 32827761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net Hospital.
    Liu A; Siddiqi N; Tapan U; Mak KS; Steiling KA; Suzuki K
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):2836-2843. PubMed ID: 36441493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in smoking prevalence and eligibility for low-dose computed tomography (LDCT) lung cancer screening among older U.S. adults: role of sexual orientation.
    Matthews AK; McCabe SE; Lee JGL; Veliz P
    Cancer Causes Control; 2018 Aug; 29(8):769-774. PubMed ID: 29948516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
    Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
    Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst the Hispanic population.
    Olazagasti C; Ehrlich M; Seetharamu N
    Front Oncol; 2022; 12():995408. PubMed ID: 36387201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach.
    Sheehan DF; Criss SD; Gazelle GS; Pandharipande PV; Kong CY
    PLoS One; 2017; 12(3):e0173119. PubMed ID: 28273181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
    Hüsing A; Kaaks R
    Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
    Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
    Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low Provider Knowledge Is Associated With Less Evidence-Based Lung Cancer Screening.
    Lewis JA; Chen H; Weaver KE; Spalluto LB; Sandler KL; Horn L; Dittus RS; Massion PP; Roumie CL; Tindle HA
    J Natl Compr Canc Netw; 2019 Apr; 17(4):339-346. PubMed ID: 30959463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST.
    Yip R; Henschke CI; Yankelevitz DF; Boffetta P; Smith JP;
    Eur J Cancer Prev; 2015 May; 24(3):201-8. PubMed ID: 25089376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
    Japuntich SJ; Krieger NH; Salvas AL; Carey MP
    J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
    Kerpel-Fronius A; Megyesfalvi Z; Markóczy Z; Solymosi D; Csányi P; Tisza J; Kecskés A; Baranyi B; Csánky E; Dóka A; Gálffy G; Göcző K; Győry C; Horváth Z; Juhász T; Kállai Á; Kincses ZT; Király Z; Király-Incze E; Kostyál L; Kovács A; Kovács A; Kuczkó É; Makra Z; Maurovich Horvát P; Merth G; Moldoványi I; Müller V; Pápai-Székely Z; Papp D; Polgár C; Rózsa P; Sárosi V; Szalai Z; Székely A; Szuhács M; Tárnoki D; Tavaszi G; Turóczi-Kirizs R; Tóth L; Urbán L; Vaskó A; Vigh É; Dome B; Bogos K
    Eur Radiol; 2024 May; 34(5):3462-3470. PubMed ID: 37921926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of Lung Cancer Screening in the Veterans Health Administration.
    Kinsinger LS; Anderson C; Kim J; Larson M; Chan SH; King HA; Rice KL; Slatore CG; Tanner NT; Pittman K; Monte RJ; McNeil RB; Grubber JM; Kelley MJ; Provenzale D; Datta SK; Sperber NS; Barnes LK; Abbott DH; Sims KJ; Whitley RL; Wu RR; Jackson GL
    JAMA Intern Med; 2017 Mar; 177(3):399-406. PubMed ID: 28135352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.
    Han SS; Ten Haaf K; Hazelton WD; Munshi VN; Jeon J; Erdogan SA; Johanson C; McMahon PM; Meza R; Kong CY; Feuer EJ; de Koning HJ; Plevritis SK
    Int J Cancer; 2017 Jun; 140(11):2436-2443. PubMed ID: 28073150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
    Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
    Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.